Factors affecting patient retention to hypertension treatment in a North Indian State: A mixed-method study

IF 2.7 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Nidhi Jaswal PhD, Sonu Goel PhD, Kritika Upadhyay MPH, Anupam Khungar Pathni MBBS, Om Prakash Bera MPH, MBA, Vandana Shah LLM
{"title":"Factors affecting patient retention to hypertension treatment in a North Indian State: A mixed-method study","authors":"Nidhi Jaswal PhD,&nbsp;Sonu Goel PhD,&nbsp;Kritika Upadhyay MPH,&nbsp;Anupam Khungar Pathni MBBS,&nbsp;Om Prakash Bera MPH, MBA,&nbsp;Vandana Shah LLM","doi":"10.1111/jch.14866","DOIUrl":null,"url":null,"abstract":"<p>Hypertension is a global health challenge, especially in low-to-middle-income countries, where awareness and control are suboptimal. Despite available treatments, poor medication adherence hampers blood pressure control, leading to adverse outcomes and increased costs. In response, the GOI has initiated national action plans to address noncommunicable diseases, including hypertension. The study aimed to analyze patient retention rates in hypertension treatment across healthcare levels and understand providers' and patients' perspectives on control factors. Using a mixed-method concurrent design in a North Indian district, retrospective data collection covered hypertensive patients registered from January 2020 to July 2020, followed for a year (August 2020–July 2021). Quantitative data included socio-demographic characteristics and patient follow-up rates. Qualitative data comprised focus group discussions (FGD) and in-depth interviews (IDI) with healthcare providers (HCPs) and patients. Findings identified challenges in patient retention and medication adherence, notably among females and at higher-level healthcare facilities, leading to substantial loss of follow-up. Only 63% of hypertensive outpatients maintained controlled blood pressure in the past year. Male patients exhibited more consistent attendance than females. Despite sufficient HCP knowledge, patient retention was better at Health and Wellness Centers (HWCs) levels, while blood pressure control was poorer at higher facilities. Barriers such as medication side effects, pill burden, and limited healthcare access hindered hypertension control, highlighting the need for improved primary care services, including extended clinic hours and diagnostic facilities. Improving hypertension control requires addressing medication adherence and healthcare access barriers. Strengthening primary care services and implementing patient-centered interventions are crucial steps.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.14866","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14866","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension is a global health challenge, especially in low-to-middle-income countries, where awareness and control are suboptimal. Despite available treatments, poor medication adherence hampers blood pressure control, leading to adverse outcomes and increased costs. In response, the GOI has initiated national action plans to address noncommunicable diseases, including hypertension. The study aimed to analyze patient retention rates in hypertension treatment across healthcare levels and understand providers' and patients' perspectives on control factors. Using a mixed-method concurrent design in a North Indian district, retrospective data collection covered hypertensive patients registered from January 2020 to July 2020, followed for a year (August 2020–July 2021). Quantitative data included socio-demographic characteristics and patient follow-up rates. Qualitative data comprised focus group discussions (FGD) and in-depth interviews (IDI) with healthcare providers (HCPs) and patients. Findings identified challenges in patient retention and medication adherence, notably among females and at higher-level healthcare facilities, leading to substantial loss of follow-up. Only 63% of hypertensive outpatients maintained controlled blood pressure in the past year. Male patients exhibited more consistent attendance than females. Despite sufficient HCP knowledge, patient retention was better at Health and Wellness Centers (HWCs) levels, while blood pressure control was poorer at higher facilities. Barriers such as medication side effects, pill burden, and limited healthcare access hindered hypertension control, highlighting the need for improved primary care services, including extended clinic hours and diagnostic facilities. Improving hypertension control requires addressing medication adherence and healthcare access barriers. Strengthening primary care services and implementing patient-centered interventions are crucial steps.

北印度邦影响患者继续接受高血压治疗的因素:混合方法研究。
高血压是一项全球性的健康挑战,尤其是在中低收入国家,这些国家对高血压的认识和控制都不尽如人意。尽管有治疗方法,但服药依从性差阻碍了血压控制,导致不良后果和成本增加。为此,印度政府启动了国家行动计划,以应对包括高血压在内的非传染性疾病。该研究旨在分析各级医疗机构的高血压治疗患者保留率,并了解医疗机构和患者对控制因素的看法。该研究在北印度的一个地区采用混合方法并行设计,回顾性数据收集涵盖了 2020 年 1 月至 2020 年 7 月登记的高血压患者,并对其进行了为期一年(2020 年 8 月至 2021 年 7 月)的随访。定量数据包括社会人口学特征和患者随访率。定性数据包括与医疗服务提供者(HCP)和患者进行的焦点小组讨论(FGD)和深度访谈(IDI)。研究结果表明,在留住患者和坚持服药方面存在挑战,尤其是在女性和较高级别的医疗机构中,导致大量患者失去随访。只有 63% 的高血压门诊患者在过去一年中保持了血压控制。男性患者比女性患者更能坚持就诊。尽管保健医生对患者有足够的了解,但在保健和健康中心(HWCs),患者的就诊率较高,而在较高级别的医疗机构,血压控制情况较差。药物副作用、药片负担和有限的医疗途径等障碍阻碍了高血压的控制,这凸显了改善初级医疗服务的必要性,包括延长门诊时间和增加诊断设施。改善高血压控制需要解决坚持服药和获得医疗服务的障碍。加强初级保健服务和实施以患者为中心的干预措施是至关重要的步骤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Hypertension
Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-
CiteScore
5.80
自引率
7.10%
发文量
191
审稿时长
4-8 weeks
期刊介绍: The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信